This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Elite Laboratories, Inc., priced at $0.3445 per EA under NDC 64850050301. Its NADAC has been published 168 times since Jun 7, 2023.
FDA first approved this application on Dec 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAM 12.5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850050301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211352FDA Approved
12/7/2018
TE Code
AB
On Market Since
12/29/2022
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 168 times since Jun 7, 2023, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3445 per EA |
|---|---|
| All-time high | $0.6346 (Jul 12, 2023) |
| All-time low | $0.2862 (Nov 20, 2024) |
| 52-week high | $0.4268 |
| 52-week low | $0.3065 |
| Median price | $0.3771 |
| Average price | $0.4164 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 168 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Elite Laboratories, Inc., is $0.3445 per EA (NDC 64850050301), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 44.0%. It has been tracked across 168 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?
Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.6346 (Jul 12, 2023), with a median of $0.3771 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?
DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 64850050301) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAM 12.5 MG TAB in shortage?
Yes — NDC 64850050301 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).